Articles tagged with Drug Targets
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers discovered a unique metabolic pathway in some tumors, potentially targeting for drug development. The reverse Krebs cycle pathway was found to run counter-clockwise in tumors, providing a new therapeutic target. This breakthrough could lead to effective treatments for certain types of cancer.
Researchers discovered that cancer drug cisplatin binds up to 20-fold more to RNA than DNA, suggesting a new approach for reducing toxic side effects. The study found platinum was retained on RNA and bound quickly, with specific locations targeted.
A new therapeutic target, EGFR, has been identified for treating Cushing disease. Clinical trials are necessary to investigate the effects of gefitinib in patients with this condition.
Researchers found that silibinin from milk thistle prevents lung cancer growth by inhibiting COX2 and iNOS production. This natural compound may be as effective as current treatments for lung cancer, targeting promising therapeutic targets STAT1 and STAT3.
Researchers at UC San Diego have identified a new class of drugs that can arrest division in virtually all tumor cells by altering the structure of the RAF enzyme. The discovery offers an effective alternative to current therapies and has shown promising results in tests on cancer cell lines, animal models, and human tissue biopsies.
Researchers have developed a method to design drugs that can target specific areas of the brain by selectively blocking subtype SK channels. This breakthrough could lead to more effective treatments for dementia and depression by enhancing nerve activity in specific nerves.
A new study by Johns Hopkins researchers reveals that US FDA testing of imported seafood is inadequate, with only 2% of imports tested, compared to 15-50% in EU, Japan, and Canada. This lack of inspection may lead to adverse health consequences due to antibiotic-resistant bacteria.
Researchers at Brown University have created an unprecedentedly detailed description of a kinase complex, which could lead to new therapeutic drugs for diseases such as Alzheimer's and cancer. The team discovered a unique binding site, called KIS, that plays a crucial role in the complex's formation.
A potential new drug target has been discovered to stop debilitating effects of MS by preventing brain cell death caused by granzyme B. The target is the M6PR receptor, which allows granzyme B to enter neurons and wreak havoc.
Researchers create entirely new platform for developing antimalarial drugs, focusing on quirk in plasmodium infection process. The goal is to design 'tailored inhibitors' that block crystal surface growth and prevent malaria spread.
Researchers found that altering a specific site on the NMDA receptor subunits reduced activity and calcium overload in neurons, potentially leading to new therapies for Alzheimer's and stroke. The discovery offers a promising opportunity for rationally designing drugs with more precise effects.
Researchers at the University of Cambridge have identified a rare genetic alteration responsible for a severe form of hypoglycemia. This discovery offers an explanation for the condition and suggests a potential target for new drugs.
Three international teams describe in unprecedented detail the workings of G protein-coupled receptors (GPCRs), a major molecular target for drugs. GPCRs are essential to human life, involved in almost every physiological function, and malfunctions have been linked to dozens of diseases.
Researchers predict numerous human proteins required by HIV to replicate, discovering potential new targets for controlling the spread of HIV. The study also identifies prognostic markers to determine pathological outcome and AIDS development.
Dr. Douglas A. Mitchell, an Illinois professor, has been awarded the $1.5 million NIH Director's New Innovator Award to develop a generalized toxin-disabling strategy against bacterial pathogens. His approach aims to create drugs that combat pathogenic microbes without promoting antibiotic resistance.
Researchers at Scripps Research Institute discovered that fetal brain damage from oxygen deprivation is linked to the action of a fatty molecule called LPA, which can be targeted with drugs. This finding provides a new strategy to limit or prevent serious developmental brain diseases.
Scientists at UCSF have identified a crucial chemical that the malaria parasite produces internally, allowing it to survive in human blood. This insight provides a powerful tool for discovering and designing new treatments.
UBC researchers identified the mechanism that leads T-cells to spring into action, providing a new target for future or existing drugs to bolster the immune systems of people with HIV or cancer. Such drugs could also be used to stop the rejection of transplanted organs or inhibit the immune system from attacking normal tissues.
A new class of drugs called cardiac myosin activators targets the motor proteins in heart failure patients, prolonging contraction duration and improving blood pumped per stroke. Omecamtiv mercabil shows promise as a safe and effective treatment option with minimal increased energy expenditure.
Researchers have devised a new technique that simplifies the improvement of drugs and other products by adding a CF3 molecule. This method reduces the need for high-heat equipment and metal catalysts, making it safer and more accessible to chemists.
Researchers at Johns Hopkins Bloomberg School of Public Health have decoded the workings of Pyrazinamide (PZA), a critical TB drug. PZA inhibits trans-translation, a process essential for cell survival under stress conditions, making it effective against non-growing bacteria called persisters.
Dimitrios Morikis and Lincoln Johnson aim to create new inhibitors of the complement system to treat the disease, which affects over 1.75 million Americans. The researchers will use computational modeling and virtual screening to identify potential treatments.
A USC scientist has created a lentiviral vector that targets and destroys HIV-infected cells using 'suicide gene therapy', depleting about 35% of existing HIV cells in culture dishes. The treatment approach is an important step towards curing HIV and will be tested in mice next.
Researchers used human hearts to replicate a mouse study on KATP ion channel drug targets, finding one target ineffective in humans. The findings underscore the importance of translating results from animal models to clinical trials in cardiovascular research.
Scientists at Joslin Diabetes Center have discovered a new connection between obesity and insulin resistance through altered protein splicing. The study suggests that changes in RNA splicing proteins may contribute to the development of type 2 diabetes, offering potential targets for novel diabetes drugs.
Researchers from the University of Melbourne have developed a new cold electron source that enables enhanced nanoimaging at the atomic or nanoscale. This technology will aid in designing better drugs and understanding material vulnerabilities, leading to advancements in health and advanced technology industries.
Researchers at UC Riverside have made a breakthrough discovery in understanding epileptic seizures by developing a computational model that simulates the cortical network. The model shows that restricting chloride increase can lead to faster seizure termination and even make seizures impossible, offering new hope for treating epilepsy.
Researchers are developing a new class of drugs targeting protein structures within cell membranes to treat autoimmune diseases. The 'membrane mimic' technology could provide a direct view of mechanical movements that take place during cell signalling.
A team of scientists has discovered that nicotine suppresses appetite by activating a specific set of neurons in the hypothalamus. The researchers believe this could lead to the development of a drug that helps smokers stay thin and potentially aids non-smokers struggling with obesity.
A clinical trial revealed crizotinib's effectiveness in shrinking tumors and improving responses in over 60% of ALK-positive advanced non-small cell lung cancer patients. The treatment has shown dramatic benefits with minimal side effects, opening new avenues for targeted therapy.
Researchers identified a key role for hedgehog in breast cancer cellular cross-talk, finding that silencing the molecule slows tumour growth and spread. The discovery applies to all breast cancers, particularly basal breast cancer, which has no current targeted therapy.
Researchers at McMaster University have discovered a new drug target that may prevent the onset of Huntington's disease by restoring a critical chemical change in the huntingtin protein. The kinase inhibitor drugs work similarly to those used for heart diseases, and could potentially delay symptom onset.
Yale researchers have found that a decoy receptor called serum sEGFR might limit the effectiveness of cancer 'smart drugs' like Cetuximab. This could explain why some patients do not respond to these treatments, even though the drug is supposed to target specific cancer cell growth drivers.
The Kunming Institute of Botany, part of the Chinese Academy of Sciences, and Springer are launching a new fully sponsored open access journal called Natural Products and Bioprospecting. This journal aims to serve as an international forum for essential research on natural products and their applications.
Researchers discovered that anti-HIV inhibitors can kill Leishmania parasites by targeting the Ddi 1 protein. This finding suggests a potential new class of drugs for treating parasitic diseases like leishmaniasis and malaria, which could one day become lifesaving treatments.
The Tissue Organization Field Theory (TOFT) of cancer origin proposes cells as the primary cause, contradicting the widely accepted Somatic Mutation Theory (SMT). The authors argue that current SMT technologies are untestable and fail to explain observable cancer phenomena.
Researchers at Emory University School of Medicine have discovered a potential mechanism that may contribute to the link between epilepsy and fragile X syndrome. The protein FMRP controls the production of a protein called Kv4.2, which regulates electrical signals in brain cells.
Researchers discovered Camel-raised Nanobody agents that target breast cancer cells, offering a new approach to identifying effective treatments for individual patients. The 'Nanobodies' are robust, small, and easy to produce at low cost, making them a promising tool in the fight against breast cancer.
Researchers identify protein TLE3 as a key regulator of fat cell development, which can be targeted to improve adipose tissue function and alleviate symptoms of diabetes. By understanding how fat cells form, scientists aim to develop better treatments for obesity and related disorders.
Researchers at Scripps Research Institute found that an E. coli enzyme must move to function properly, and blocking these movements renders it defective. The study may lead to the development of more specific and effective drugs targeting enzymes.
A Purdue University biochemist has created a nanopolymer that can be coated with drugs and then removed to determine which proteins the drug has entered. This development may help reduce side effects associated with cancer drugs by allowing for more targeted drug delivery.
The article discusses the resurgence of covalent drugs, which have made a major positive impact on human health, and highlights the potential of rational covalent drug design to expand their use. Several rationally designed covalent inhibitors are advancing in clinical development, addressing problems of drug-resistance mutations.
Researchers found that HIV requires base excision repair proteins to integrate its DNA into the host genome, identifying novel targets for anti-HIV drugs. The study suggests that drugs targeting these cellular proteins may avoid resistance and have fewer side effects.
A clinical trial found that adding omalizumab to standard therapy reduced asthma symptoms in children and young people with moderate to severe disease. The study showed a 25% reduction in days with symptoms and a 30% reduction in asthma attacks, as well as a significant decrease in hospitalizations.
Professor Sylvain Martel's team at Polytechnique Montréal successfully guided microcarriers loaded with an anti-cancer drug to a targeted area in the liver, where it was administered. This breakthrough improves chemoembolization treatment for liver cancer by precisely targeting cancerous cells without harming surrounding tissue.
Scientists at Scripps Research Institute and University of Pennsylvania discovered over 400 receptors in warm sensitive neurons, which regulate body temperature. The new method, sequencing single neurons, identified these receptors, revealing their role in diseases like schizophrenia and Parkinson
Researchers at Harvard School of Dental Medicine found that blocking the Klotho protein function in obese mice with high blood sugar levels led to lean mice with reduced blood sugar levels. Additionally, mice without Klotho function gained no body weight after eating a high-fat diet.
A team of researchers has discovered a new enzyme, squalene mono-oxygenase (SM), that plays a key role in cholesterol production. Inhibiting SM may lead to more effective treatments with fewer side effects than current medications.
Researchers at the Ohio State University Comprehensive Cancer Center found that combining rituximab with fludarabine can produce long-term remissions in CLL patients. After nearly 10 years of follow-up, 13% of patients achieved remissions lasting more than seven years.
Researchers at Cedars-Sinai Medical Center have created a new molecule from curcumin, a key spice in Indian and Southeast Asian cuisine, that affects mechanisms protecting and helping regenerate brain cells after stroke. The compound, CNB-001, crosses the blood-brain barrier and moderates critical pathways involved in neuronal survival.
Researchers have developed a 3D model of Human 5-Lipoxygenase, the molecule responsible for creating inflammatory compounds that provoke asthma. This breakthrough could lead to more effective and targeted asthma medications with fewer side effects.
A new study reveals that estrogen receptors in the liver are critical for maintaining fertility, with dietary protein playing a crucial role. The researchers found that mice on calorie-restricted diets showed reduced reproductive cycles, but those given more protein restored normal function.
Researchers at National Jewish Health have discovered a critical signaling pathway involved in acute lung injury (ALI), which causes 40% mortality with no approved therapy. The study identified HER2 as a promising target for therapy, building on existing breast-cancer medications.
Scientists have determined the structure and mechanism of a key enzyme in Staphylococcus aureus that produces cholesterol and a virulence factor. This breakthrough could lead to new cholesterol-lowering drugs and antibiotics against staph infections, as well as treatments for parasitic diseases.
Researchers have developed a groundbreaking technique to visualize cellular changes in deep brain regions, providing insight into addiction and brain tumors. The study used time-lapse fluorescence microendoscopy to track structural changes in neurons over weeks.
Scientists have developed a technique to freeze the adrenaline receptor in one position, allowing them to determine its structure and develop new or better drugs. This breakthrough has significant prospects for medicine, particularly for treating asthma and heart disease, as well as understanding other GPCRs.
Researchers created a model predicting a drug's likelihood of causing birth defects by analyzing genes targeted by the medication. The model showed 79% accuracy in classifying drugs as safe or known to be teratogenic.
A new study found that deep brain stimulation (DBS) targets the same class of neuronal cells known to respond to exercise and Prozac, leading to an increase in new neurons in the hippocampus. The targeted area, anterior thalamic nucleus, may provide a guide for designing better treatments.
A team of researchers found that the protein LXR-beta is necessary for glucocorticoid drugs to cause severe side effects. In mice lacking LXR-beta, high blood glucose and fatty liver were avoided but immunosuppression remained.
Researchers have discovered that plasminogen, a protein that breaks down blood clots, accelerates the progression of prion diseases by putting rogue prion proteins into overdrive. This finding presents a promising new target for anti-prion therapy, which could improve treatment options for patients suffering from prion diseases.